Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001720067 | SCV000518982 | likely benign | not provided | 2019-07-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003743708 | SCV000562581 | likely benign | Familial adenomatous polyposis 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000568024 | SCV000667311 | likely benign | Hereditary cancer-predisposing syndrome | 2015-03-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000568024 | SCV000681440 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-08 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000568024 | SCV002528796 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-08 | criteria provided, single submitter | curation | |
Prevention |
RCV003897861 | SCV004716087 | likely benign | APC-related condition | 2023-03-06 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |